UCLA research could lead to a simple saliva test capable of diagnosing—at an early stage—diabetes and cancer, and perhaps neurological disorders and autoimmune diseases.
Analytical Chemistry
Oct 29, 2014
0
0
Scientists have created the first completely artificial protein switch that can work inside living cells to modify—or even commandeer—the cell's complex internal circuitry.
Biochemistry
Jul 24, 2019
5
634
A glucosamine-like dietary supplement suppresses the damaging autoimmune response seen in multiple sclerosis, according to a UC Irvine study.
Biochemistry
Sep 30, 2011
2
0
Biologists at The University of Texas at Arlington have demonstrated that removing water molecules can deactivate caspase-3 enzymes, which opens new doors for treatment of autoimmune diseases like arthritis, which have been ...
Biochemistry
Sep 28, 2016
0
195
(Phys.org) —Grapefruits have long been known for their health benefits, and the subtropical fruit may revolutionize how medical therapies like anti-cancer drugs are delivered to specific tumor cells. University of Louisville ...
Bio & Medicine
May 21, 2013
1
1
A researcher at the University of Tartu described new associations between Neandertal DNA and autoimmune diseases, prostate cancer and type 2 diabetes.
Evolution
Dec 3, 2020
2
39
Beer tested in a new study, including some brands labeled "low-gluten," contains levels of hordein, the form of gluten present in barley, that could cause symptoms in patients with celiac disease (CD), the autoimmune condition ...
Other
Dec 21, 2011
0
0
When targeting problem proteins involved in causing or spreading disease, a drug will often clog up a protein's active site so it can't function and wreak havoc. New strategies for dealing with these proteins can send these ...
Cell & Microbiology
Oct 25, 2023
0
32
Scientists have sequenced the genome of the fungus Pneumocystis jirovecii, an advancement that could help identify new targets for drugs to treat and prevent Pneumocystis pneumonia, a common and often deadly infection in ...
Biotechnology
Dec 26, 2012
0
0
Drugs available to treat multiple sclerosis, a leading cause of neurological disability affecting roughly 2.3 million people worldwide, alter the body's immune system to reduce disease symptoms and disability.
Biochemistry
May 29, 2018
1
241
